Aubrey O’Day has shared her reaction to the results of Sean “Diddy” Combs‘ trial, which concluded Wednesday (July 2) with a ...

A group of faith leaders, community advocates, and activists continues to call on the Monroe County District Attorney’s ...

The Adelaide mom is met with sympathy, her husband with praise and both of them cop opinions that belong back in 1963. She’s ...

Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and ...

There had been a fleeting window of sympathy, and then the story flipped. Israel’s military steps became the headline—its ...

Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has now shown its ...

Pfizer said a late-stage study of its Hympavzi hemophilia drug met its key goals in patients with the blood-clotting disorder who have inhibitors that can render some treatments ineffective.

The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...

ICE raids are disrupting worksites across the country, particularly construction sites, as President Trump’s mass deportation ...

Meet Emanuel Colombini of Eccentrica Cars, whose Lamborghini Diablo restomod is an analogue supercar for the modern age ...

Results from the Phase III BASIS trial show that once-weekly subcutaneous Hympavzi reduced annualized bleeding rates by 93% ...

Responses cited increasing workloads, shrinking autonomy, mounting interference from hospital administrators and insurance ...